Rein Therapeutics, Inc. — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-19M
Free Cash Flow
$-19M
Investing Cash Flow
$0
Financing Cash Flow
$10M
Capex
—
Acquisitions
$0
Stock-Based Comp
$2M
D&A
$1K
SBC Allocated Expense
$2M
SBC Unrecognized Cost
$1M